MedPath

The effect of Nigella Sativa on diabetic neuropathy

Phase 3
Conditions
diabetic neuropathy.
Diabetes mellitus due to underlying condition with diabetic neuropathy, unspecified
E08.40
Registration Number
IRCT20160221026684N2
Lead Sponsor
Yazd University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
120
Inclusion Criteria

Type 2 diabetes mellitus
with diabetic neuropathy diagnosed by neurologist
resident of Yazd
controlled glucose (HbA1c less than 9)

Exclusion Criteria

Spinal Disorders and Discopathy
Heart disorder
Renal disorder
Liver disorder
Active foot ulcer
Autoimmune diseases
mental illnesses
Drug and alcohol addiction
Skin diseases in the area of drug use
Severe foot vascular disorders

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath